InvestorsHub Logo
Followers 87
Posts 6772
Boards Moderated 1
Alias Born 09/18/2009

Re: shajandr post# 40610

Friday, 09/22/2023 12:40:56 PM

Friday, September 22, 2023 12:40:56 PM

Post# of 43157
While I have previously recognized lenzilumab's potential to enhance CAR-T efficacy as it may relate to TeraImmune, I think Gracell's CAR-T technology expands on that, and illustrates a broader scope for lenz in CAR-T.
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.